Advisor Group Holdings, Inc. Onconova Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.57 - $1.0 $168 - $296	296 Added 2960.0%	306 $0
Q1 2024 May 10, 2024	BUY	$0.67 - $1.01 $4 - $6	6 Added 150.0%	10 $0
Q4 2023 Feb 12, 2024	SELL	$0.62 - $0.79 $620 - $790	-1,000 Reduced 99.6%	4 $0
Q1 2023 May 12, 2023	BUY	$0.69 - $1.42 $690 - $1,420	1,000 Added 25000.0%	1,004 $0
Q3 2022 Nov 14, 2022	SELL	$0.95 - $1.45 $5 - $8	-6 Reduced 60.0%	4 $0
Q2 2022 Aug 10, 2022	BUY	$1.04 - $1.9 $10 - $19	10 New	10 $0
Q1 2022 May 04, 2022	SELL	$1.46 - $2.82 $5 - $11	-4 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$6.28 - $16.2 $25 - $64	4 New	4 $0

276K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.